Position in CYTK
as of Mar 31, 2026
· filed May 14, 2026
Position Value
$4,586,215
New position
Shares Held
69,583
first reported quarter
Ownership
0.056%
of shares outstanding
% of Portfolio
0.76%
of 13F equity value
Holder Rank
—
not a current holder
Holding Since
Mar 2026
1 quarter on record
Voting authority
Sole 64%
Shared 0%
None 36%
Position in Biotechnology
Healthcare · as of Mar 31, 2026Pier Capital, LLC holds $20,446,999 across 6 Biotechnology names. CYTK ranks #2 (22.4% of the industry book) .
| # | Ticker | Company | Shares | Value (USD) | Open |
|---|---|---|---|---|---|
| 1 | ROIV |
Roivant Sciences Ltd.
|
227,093 | $6,290,476 | |
| 2 | CYTK |
Cytokinetics Inc
This page
|
69,583 | $4,586,215 | |
| 3 | COGT |
Cogent Biosciences, Inc.
|
101,304 | $3,899,190 | |
| 4 | GPCR |
Structure Therapeutics Inc.
|
47,551 | $2,291,958 | |
| 5 | OLMA |
Olema Pharmaceuticals, Inc.
|
136,108 | $2,029,370 | |
| 6 | CAPR |
Capricor Therapeutics, Inc.
|
44,401 | $1,349,790 |
All Filings in CYTK
Export CSV
1 filing row on record
| Report Date | Value (USD) | Shares | Type | Discretion | Filed | |
|---|---|---|---|---|---|---|
| 2026-03-31 | $4,586,215 | 69,583 | Shares | Sole | 2026-05-14 | |
| No filing history on record for this holder in this stock. | ||||||